These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8877401)

  • 1. Allogeneic recognition of HLA-DRB1*0406 by T cells with HLA-DRB1*0403: role of amino acid residue 37 on the beta sheet in T cell recognition.
    Kaneko T; Obata F
    Immunobiology; 1996 Aug; 195(3):261-70. PubMed ID: 8877401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single residue polymorphism at DR beta 37 affects recognition of peptides by T cells.
    Chen YZ; Matsushita S; Nishimura Y
    Hum Immunol; 1997 Apr; 54(1):30-9. PubMed ID: 9154455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sharing of four DR-beta sequence motifs between HLA-DRB1*1601 and DRB1*1101 correlates with frequent degenerate T-cell recognition of HA306-320 peptide complexed to these two molecules.
    Zeliszewski D; Dorval I; Golvano JJ; Prevost A; Borras-Cuesta F; Sterkers G
    Scand J Immunol; 1996 Feb; 43(2):146-54. PubMed ID: 8633194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
    Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
    Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific alphabeta+ T cell clones.
    Zanni MP; von Greyerz S; Schnyder B; Wendland T; Pichler WJ
    Int Immunol; 1998 Apr; 10(4):507-15. PubMed ID: 9620607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of a myelin basic protein-specific human T cell clone by antigen-presenting cells from rhesus monkeys.
    Meinl E; t Hart BA; Bontrop RE; Hoch RM; Iglesias A; de Waal Malefyt R; Fickenscher H; Müller-Fleckenstein I; Fleckenstein B; Wekerle H
    Int Immunol; 1995 Sep; 7(9):1489-95. PubMed ID: 7495756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype.
    Ou D; Mitchell LA; Décarie D; Tingle AJ; Nepom GT
    Hum Immunol; 1998 Mar; 59(3):149-57. PubMed ID: 9548074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones.
    Tommasi M; Castelletti D; Pasti M; Fracasso G; Lorenzetti I; Sartoris S; Pera C; Ferrara GB; Tridente G; Colombatti M
    Clin Exp Immunol; 2001 Sep; 125(3):391-400. PubMed ID: 11531946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for degenerate T-cell recognition of one peptide in the context of several DR molecules.
    Zeliszewski D; Gaudebout P; Golvano JJ; Dorval I; Prévost A; Borras-Cuesta F; Sterkers G
    Hum Immunol; 1994 Sep; 41(1):28-33. PubMed ID: 7836061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DR-restricted T-cell reactivities associated with the Dw19 specificity can be directed against the products of either locus DRB3 (DRw52c) or locus DRB1.
    Zeliszewski D; Tiercy JM; Dorval I; Kaplan C; Mach B; Sterkers G
    Hum Immunol; 1990 Aug; 28(4):345-53. PubMed ID: 2391250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased T-cell receptor usage is associated with allelic variation in the MHC class II peptide binding groove.
    Yassine-Diab B; Carmichael P; L'Faqihi FE; Lombardi G; Deacock S; de Préval C; Coppin H; Lechler RI
    Immunogenetics; 1999 Jun; 49(6):532-40. PubMed ID: 10380698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restrictions in the repertoire of allospecific T cells. Contribution of the alpha-helical sequence polymorphism of HLA-DR molecules.
    Goronzy JJ; Xie C; Hu W; Lundy SK; Weyand CM
    J Immunol; 1993 Jul; 151(2):825-36. PubMed ID: 8335912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms.
    Fujita H; Senju S; Yokomizo H; Saya H; Ogawa M; Matsushita S; Nishimura Y
    Eur J Immunol; 1998 Jan; 28(1):305-16. PubMed ID: 9485210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of three quantitatively dominant endogenous peptides from HLA-DRB1*0401 molecules in class II specific alloreactivity.
    Adibzadeh M; Friccius H; Bornhak S; Max H; Hambrecht A; Sansom D; Kalbacher H; Schenk A; Pohla H; Pawelec G
    Transpl Immunol; 1994 Dec; 2(4):293-9. PubMed ID: 7704539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity.
    Frasca L; Tamir A; Jurcevic S; Marinari B; Monizio A; Sorrentino R; Carbonari M; Piccolella E; Lechler RI; Lombardi G
    Transplantation; 2000 Aug; 70(4):631-40. PubMed ID: 10972222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide recognition by T-cell clones of an HLA-DRB1*1501/*0901 heterozygous donor is promiscuous only between parental alleles.
    Agrewala JN; Deacock S; Jurcevic S; Wilkinson R
    Hum Immunol; 1997 Jun; 55(1):34-8. PubMed ID: 9328787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new MHC-restriction elements for presentation of the p210(BCR-ABL) fusion region to human cytotoxic T lymphocytes.
    Sun JY; Senitzer D; Forman SJ; Chatterjee S; Wong KK
    Cancer Immunol Immunother; 2003 Dec; 52(12):761-70. PubMed ID: 14564482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective T cell receptor Vbeta gene usage by alloreactive T cells responding to defined HLA-DR alleles.
    Lobashevsky A; Kotb M; Gaber AO
    Transplantation; 1996 Nov; 62(9):1332-40. PubMed ID: 8932281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.